Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol for painless gastrointestinal tumor screening in elderly patients with hypertension
ChiCTR2400083757Phase 4Not yet recruiting
- Sponsor
- Sichuan Cancer Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hypertension (HTN) comparing Remimazolam group with Propofol group (2 arms). Primary endpoints: Incidence of hypotension and Cardiac function indices. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
remimazolampropofol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2400083757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083757.